Common Stock, Shares, Outstanding of Enliven Therapeutics, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Enliven Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Enliven Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 59,440,045, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Enliven Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 59,440,045 +10,503,586 +21% 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 59,261,286 +12,007,006 +25% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 59,226,171 +12,052,705 +26% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 49,038,730 +2,256,091 +4.8% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 48,936,459 +7,644,432 +19% 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 47,254,280 +6,049,307 +15% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 47,173,466 +6,022,355 +15% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 46,782,639 +5,676,362 +14% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 41,292,027 +37,722,008 +1057% 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 41,204,973 +14,917,709 +57% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 41,151,111 +14,863,847 +57% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 41,106,277 +14,819,013 +56% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 3,570,019 +135,005 +3.9% 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 26,287,264 +11,542 +0.04% 30 Sep 2022 10-Q 25 Oct 2022 2022 Q3
Q2 2022 26,287,264 +8,376,327 +47% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 26,287,264 +8,670,722 +49% 31 Mar 2022 10-Q 06 May 2022 2022 Q1
Q4 2021 3,435,014 -14,113,249 -80% 31 Dec 2021 8-K 23 Jun 2023
Q3 2021 26,275,722 +8,898,655 +51% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 17,910,937 +586,201 +3.4% 30 Jun 2021 10-Q 06 Aug 2021 2021 Q2
Q1 2021 17,616,542 +1,041,077 +6.3% 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 17,548,263 +16,845,753 +2398% 31 Dec 2020 10-K 15 Mar 2022 2021 FY
Q3 2020 17,377,067 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 17,324,736 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 16,575,465 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 702,510 31 Dec 2019 10-K 05 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.